Aurobindo Pharma intimates dismissal of promoter group's writ petition against SEBI's settlement order.
SEBI directed promoters to deposit ₹6.53 crore profits plus 12% interest for insider trading violations.
The High Court of Telangana dismissed the petition, upholding SEBI's 2020 settlement communication.
The company confirms no financial or operational impact from the order against its promoters.